In terms of clinicopathological characteristics, the high expression levels of six drug resistance-associated lncRNAs, namely, ADAMTS9-AS2 [32], BCAR4 [38], FGD5-AS1 [51], PANDAR [86], SLCO1C1 [91], and UCA1 [97], were found to be positively correlated with tumor size. This evidence concerns the gene BCAR4 and neoplasm.